Abstract. Two genetically distinct classes of low density lipoprotein (LDL) receptor-deficient Chinese hamster ovary cell mutants, ldlB and ldlC, exhibit nearly identical pleiotropic defects in multiple medial and trans Golgi-associated processes (Kingsley, D., K. F. Kozarsky, M. Segal, and M. Krieger. 1986. J. Cell Biol. 102:1576-1585. In these mutants, the synthesis of virtually all N-and O-linked glycoproteins and of the major lipid-linked oligosaccharides is abnormal. The abnormal glycosylation of LDL receptors in ldlB and ldlC cells results in their dramatically reduced stability and thus very low LDL receptor activity. We have cloned and sequenced a human cDNA (LDLC) which corrects the mutant phenotypes of ldlC, but not ldlB, cells. Unlike wild-type CHO or ldlB cells, ldlC cells had virtually no detectable endogenous LDLC mRNA, indicating that LDLC is likely to be the normal human homologue of the defective gene in ldlC cells. The predicted sequence of the human LDLC protein (ldlCp, m83 kD) is not similar to that of any known proteins, and contains no major common structural motifs such as transmembrane domains or an ER translocation signal sequence. We have also determined the sequence of the Caenorhabditis elegans ldlCp by eDNA cloning and sequencing. Its similarity to that of human ldlCp suggests that ldlCp mediates a well-conserved cellular function. Immunofluorescence studies with anti-ldlCp antibodies in mammalian cells established that ldlCp is a peripheral Golgi protein whose association with the Golgi is brefeldin A sensitive. In ldlB cells, ldlCp was expressed at normal levels; however, it was not associated with the Golgi. Thus, a combination of somatic cell and molecular genetics has identified a previously unrecognized protein, ldlCp, which is required for multiple Golgi functions and whose peripheral association with the Golgi is both LDLB dependent and brefeldin A sensitive.
LDLC protein (ldlCp, m83 kD) is not similar to that of any known proteins, and contains no major common structural motifs such as transmembrane domains or an ER translocation signal sequence. We have also determined the sequence of the Caenorhabditis elegans ldlCp by eDNA cloning and sequencing. Its similarity to that of human ldlCp suggests that ldlCp mediates a well-conserved cellular function. Immunofluorescence studies with anti-ldlCp antibodies in mammalian cells established that ldlCp is a peripheral Golgi protein whose association with the Golgi is brefeldin A sensitive. In ldlB cells, ldlCp was expressed at normal levels; however, it was not associated with the Golgi. Thus, a combination of somatic cell and molecular genetics has identified a previously unrecognized protein, ldlCp, which is required for multiple Golgi functions and whose peripheral association with the Golgi is both LDLB dependent and brefeldin A sensitive.
I
N euk~aryotes, nascent secretory and integral membrane proteins, glycosaminoglycans, and glycolipids typically traverse the Golgi en route to their final destinations. Often, chemical modification of these molecules within the Golgi is essential for their stability or function. For example, mucin-type serine/threonine-linked (O-linked) oligosaccharides are known to protect from rapid proteolysis several cell surface proteins, including the low density lipoprotein (LDL) t receptor (Krieger et al., 1985) , decay-accelerating factor , the Epstein-Barr virus envelope protein , and glycophorin (Remaley et al., 1991) . Also, asparagine-linked (N-linked) glycosylation is required for normal folding, assembly, and intracellular transport of proteins such as the vesicular stomatitis virus G protein and the influenza virus hemagglutinin protein (Rose and Doms, 1988; Doms et al., 1993) . Although previous biochemical and genetic analyses have uncovered a wealth of information about the molecular mechanisms underlying intracellular protein transport and processing in the Golgi (Kornfeld and Kornfeld, 1985; Hirschberg and Snider, 1987; Rothman and Orci, 1992) , much remains to be learned about the structure and function of the Golgi.
To help define and analyze the gene products and functions required for normal Golgi activity, we have analyzed mutant CHO cells with defects in LDL receptor activity (Krieger et al., 1981 (Krieger et al., , 1983 (Krieger et al., , 1985 Krieger, 1983; Malmstrom and Krieger, 1991; Hobbie et al., 1994) . These mutants define nine complementation groups, designated ldlA through ldlI (Kingsley and Krieger, 1984; Malmstrom and Krieger, 1991; Hobbie et al., 1994) . The LDL receptor deficiency of mutants in two of these groups, ldlB and ldlC, is a consequence of dramatically decreased LDL receptor stability due to ab-normal posttranslational processing of the receptor in the Golgi (Kingsley et al., 1986a) . At least in the case of ldlC cells, this aberrant processing and the resulting instability do not prevent the initial appearance of the abnormal receptors on the cell surface and do not alter the receptors' ligandbinding and endocytic properties (Kingsley et al., 1986a; . ldlB and ldlC exhibit nearly identical pleiotropic defects in medial and trans Golgi-associated processes, which result in the abnormal synthesis of virtually all N-linked, O-linked and lipid-linked glycoconjugates (Kingsley et al., 1986a) . The global nature of the glycosylation defects in these mutants was demonstrated both by examining the synthesis of several distinct molecules (LDL receptor, vesicular stomatitis virus G protein, the major surface glycolipid GM3), and by establishing that the mutants exhibit abnormal sensitivities to a panel of toxic plant lectins. In contrast to many other glycosylation mutants (Stanley, 1985; Kingsley et al., 1986c) , the diverse defects in these mutants cannot readily be explained by single deficiencies in the activities of either a glycosidase or a glycosyltransferase. Therefore, we have suggested that the genes defined by these mutants may affect the regulation, compartmentalization, or activity of several different Golgi enzymes or substrates (Kingsley et al., 1986a) . The primary biochemical defects in these cells might cause Golgi disruptions by: (a) blocking the synthesis of small and/or macromolecular substrates or their access to Golgi enzymes; (b) blocking Golgi enzyme transport to or retention at the appropriate site; (c) preventing the posttranslational activation or stabilization of multiple Golgi enzymes; (d) disrupting the basic structure of the Golgi or its lumenal environment (pH, ion concentrations); or (e) some combination of these.
In the current work, we isolated a novel human cDNA (LDLC) that corrects all of the pleiotropic defects in ldlC cells, and we also isolated an LDLC homologue from Caenorhabditis elegans. We have examined the expression of the LDLC gene and its protein product (ldlCp), and the intracellular distribution of ldlCp, in wild-type CHO and mutant ldlC and ldlB cells, ldlCp is a peripheral Golgi protein whose association with the Golgi is dependent on the LDLB gene and sensitive to the drug brefeldin A. The high degree of similarity between the sequences of the human and C. elegans LDLC cDNAs suggests that ldlCp mediates a wellconserved cellular function. Thus, somatic cell genetic analysis of LDL receptor activity has defined a previously unrecognized gene which plays an important role in establishing or maintaining multiple Golgi functions. Additional molecular genetic and biochemical analysis of the LDLB/ LDLC system should provide new insights into Golgi structure and function.
Materials and Methods

Materials
Reagents (and sources) were: methionine-and cysteine-free Ham's Fl2 medium (GIBCO BRL, Grand Island, NY); Na125I (Amersham Corp., Arlington Heights, IL); c~[32p]dCTP, [35S]methionine, and [3SS]dATP-a-S(>1000 Ci/mmol) (DuPont NEN, Boston, MA); fluorescein-conjngated goat anti-rabbit (FGAR) and goat anti-mouse (FGAM) IgGs (Cappel Research Reagents, Organon, Teknika, Durham, NC); Texas red-conjugated horse anti-mouse IgG (TRHAM) (Vector Laboratories, Budingame, CA); and cell culture media and supplements (GIBCO BRL or Hazelton/JRH, Lenexa, KA). Newborn calf lipoprotein-deficient serum, LDL, and 125I-LDL were prepared as previously described (Kriager, 1983) . Lectins were purchased from Signm Chemical Co., St. Louis, MO. Other reagents were obtained as previously described (Kriager, 1983) or were purchased from standard commercial suppliers. Compactin was a gift of A. Endo (Tokyo Nodo University, Japan). Antibodies used fvr immunofluorescence localization experiments include a polyclonal antiserum against Golgi mannosidase II (Moremen and Toustcr, 1985) , and the anti-~-COP monoclonal antibody M3A5 (Allan and Krcis, 1986) .
Cell Culture
All incubations with intact cells were performed at 37°C in a humidified 5 % CO2/95 % air incubator unless specified otherwise. Wild-type CHO cells, ldlC (clone 475) and ldlB (clones 11 and WGAr-2) mutant CHO cells, and the transfectant LETB-144 were obtained as previously described (Kriager et ai., 1981; Kingsley and Krieger, 1984; Kingsley et al., 1986a,b) and were maintained in medium A (Ham's FI2 containing glutamine [2 raM], penicillin [50 U/ml I and streptomycin [50/~g/ml]), supplemented with either 5% (vol/vol) (medium B) or 10% (vol/vol) (medium C) FBS. Human HeLa and murine NIH 3T3 cells were obtained from P. Sharp and E Solomon, M. L T. (Cambridge, MA). HeLa cells were maintained in medium B or C. 3T3 cells were maintained in medium D (Dulbecco's Modified Eagle Medium with glutamine, penicillin, streptomycin, and 5 % [vol/vol] FBS). ldlC transfectants were maintained with or without 250 /zg/ml (3418 in either medium B or medium E which is composed of medium E (medium A with 3 % [vol/vol] newborn calf lipoprotein-deficient serum) supplemented with MeLoCo (250 #M mevalonate, 2.5 /~g protein/ml LDL, and 40 t~M compactin). Compactin, an inhibitor of HMGCoA reductase, prevents ~holesterol synthesis by inhibiting all mevalonate synthesis, with the supplemented mevalonate providing only enough precursor for nonsteroidal isoprenoid synthesis; thus, the LDL is the only source of cholesterol for cell growth (Goldstein et al., 1979; Krieger, 1986) . Consequanily, cells can grow in medium F containing MeLoCo only if they express essentially normal levels of functional LDL receptors.
Isolation of LDL Receptor-positive Genomic
Transfectants from ldlC Cells ldlC cells were transfected with calcium phosphate precipitates of human genomic DNA essentially as described by Graham and Van der Eb (1973) . In brief, ldlC cells were plated on day 0 in medium B (500,000 cells/ 100-mm dish), and on day 2 the medium from each dish was replaced with 1.5 ml of Hepes-buffered saline containing a calcium phosphate precipitate of genornic DNA from human A431 carcinoma cells (20 /~g/dish) and pSV2neo DNA (1/tg/dish). After 10 min, 10 ml of medium B were added. After a 5-h incubation, the DNA-calcium phosphate solution was removed and the cells in each dish were shocked with 2 ml of 15% glycerol in Hepes buffered saline for 3 min, washed twice in Ham's F12 medium, and incubated overnight in medium B. On day 3, the cells were refed with medium B and on day 4 harvested with trypsin/EDTA. Cells from each transfection dish were then reset into 2 100-ram dishes (4 x 106 cells/dish) in MeLoCo selection medium (medium F) containing 250 ~g/ml G418, to isolate primary receptor-positive LDL endocytosis transfectants of ldlC cells (1 ° LETC cells). Five independent 1 ° LETC colonies were isolated from a total of 2 x 108 cells subjected to selection. Seven independent secondary LETC (2 ° LETC) colonies were then isolated from 2 x 10 s cells by a second round of the cotransfection/selection procedure, except that genomic DNA isolated from one of the 1 ° LETC colonies (1 ° LETC-3C) was used in place of the A431 DNA. Finally, seven tertiary LETC (3 ° LETC) colonies were isolated from 6 x 10 s cells after a third round of cotransfection/selection, using a 2 ° LETC colony (2* LETC-I5) as the source of genomic DNA.
Cloning Human LDLC cDNA A 3.5-bp EcoRI DNA fragment was detected in the 2 ° LETC and 3 ° LETC colonies by Southern blot analysis, using BLURll, a human Alu repeat element, as a probe (Jelinek et al., 1980 ). The BLURll probe was then used to clone the 3.5-kbp fragment from a kZAPU (Stratagene Inc., La Jolla, CA) library of EcoRI-digested, size-selected DNA from 2 ° LETC cells (colony VS). A 600-bp SacI-HincII restriction fragment from the 3.5-kbp EcoRI clone, which did not contain the Alu repeat element, was then used as a probe to isolate candidate LDLC cDNAs from two eDNA libraries.
These libraries were prepared from human HeLa cell poly(A) + RNA, synthesized both from random hexamer primers (Amersham) and from oligo d(T) 12-18 primers (Pharmacia LKB Biotechnology, Inc., Piseataway, NJ) as previously described (Ashkenas et al., 1993) . The cDNAs were ligated to EcoRI/NotI adaptors (Pharmacia), size-selected (>1 kbp) by sedimentation through 5-20% KOAc gradients, and packaged into EcoRI-digested kZAPII. Plaques (5 × 10 s) from the random-primed library were transferred to nitrocellulose for hybridization. Eight positive clones (1-8) were identified, and eDNA from these clones was then used to isolate eight additional clones (9-16) from the oligo d(T) primed library, pBluescript constructs beating cDNA clones 1-16 were excised from the ~ZAPII clones according to the manufacturer's instructions. Partial or complete sequences on one or both strands from all 16 clones were determined using internal and pBhiescript primers with Sequenase 2 (United States Biochemical Corp., Cleveland, OH), and were assembled into a single consensus sequence (EMBL accession number Z34975) with Staden DNA and protein analysis soRware (Cambridge, UK; see e.g., Staden, 1990) . Clone 2, which encompasses the complete protein coding sequence (bases 1-2214), was fully sequenced on both strands. Clone 2 starts at base -15 and continues through base 2780. The sequence of the 3' most 92 bases in clone 2 does not match the consensus sequence derived from the other clones. This divergent sequence is: 5"AGCTAGCTAG CTAGCTAGCT AGCTAGCTAG CTAGCTAGCT AGCTAGCTAG CTAGCTAGCT AGCTAGCTAG CTA-GCTAGCT AGCTAGCTAG CT-3'. Surveys of sequence databases and analysis of protein sequence motifs were performed using the programs FASTA and MOTIFS (with PROSITE database, version 10.2, from Amos Bairoch, Geneva, Switzerland) from the Sequence Analysis Software Package from the Genetics Computer Group at the University of Wisconsin (versions through 7.3) (Devereux et al., 1984) , and BLAST from NCBI (Altschul et al., 1990) .
Transfection of LDLC cDNA into ldlC Cells
The full-length eDNA insert from clone 2 was inserted into the plasmid pRc/CMV (Invitrogen, San Diego, CA) to generate the expression construct pLDLC-1, pLDLC-1 DNA was transfected into ldlC cells using polybrene (Kawai and Nishizawa, 1984) . Transfected cells were isolated by selection in medium B containing 250/~g/ml G418. In some cases, transfectants were isolated by incubation in MeLoCo selection medium F with G418, to select directly for LDL receptor-positive transfectants. One colony transfected with pLDLC-I, designated IdlC[LDLCI, was used for all eDNA transfectant experiments presented here, and all results were verified using independently isolated transfectants (not shown).
Cloning a C. elegans Homologue of LDLC
The C. elegans eDNA fragment CEESWg0 (GenBank accession number T01892) was identified as a potential LDLC homologne (see Results). A probe comprising sequences from CEESWg0 was generated by PCR amplification of C. elegans genomic DNA using the oligonucleotide primers ATGCd3TACACTTCA~GA and CGATTCTTTCAGCCATACCAAC.
This probe was used to screen a C. elegans eDNA library in )~ZAP (Stratagene), prepared by R. Barstead, Washington University (St. Louis, MO). Six eDNA clones were isolated from 500,000 ~ZAP plaques, each clone being '~2.0 kbp. One clone was sequenced on both strands, and its sequence (EMBL accession number Z34976) was analyzed as described above for the human LDLC. The sequence of its protein product was compared to that of the human protein using the BESTFIT program from the Genetics Computer Group, and the amino acid similarities described in Guo et al., 1994 (see Fig. 4 B) .
Preparation of Polyclonal Anti-ldlCp Antipeptide Antibodies
Peptides Npep (EKSRMNLPKGPDTLC) and Cpep (CAELVAAAKDQAT-AEQP) were synthesized containing the predicted NH2-terminal and COOH-terminal sequences of the ldlC protein, with terminal cysteines added to permit crosslinking to carrier proteins. Npep and Cpep were coupled to keyhole limpet hemocyanin (Sigma) preactivated with m-maleimidobenzoic acid N-hydroxysuccinimide ester (Sigma), and these complexes were used to prepare polyclonal antibodies in New Zealand white rabbits. Preimmune and immune IgGs were isolated on Protein A-Sepharose (Pharmacia) columns and are designated preimmune IgG, anti-Npep, and anti-Cpep. For some experiments, anti-Cpep was affinity-purified on a Cpep-agarnse column prepared by coupling ",,6 mg of Cpep to a 2 rnl SolfoLink column (Pierce Chem. Co., Rockford, IL); anti-Cpep was isolated after adsorption to the column by washing the column with 100 mM Tris (pH 8.0), and eluting with 100 mM glyeine (pH 2.5).
Immunoblot Analysis
Cells were grown to confluence in medium C in 150-rmn dishes, veashed and collected in PBS, lysed by addition of an equal volume of 2 × sample buffer with protease inhibitors (final concentrations: 60 mM Tris [pH 6.8], 2% [wt/vol] SDS, 10% [vol/vol] glycerol, 0.71 M 13-mercaptoethanol, 1.5 t~g/ml aprotinin, 2 #M leupeptin, 10/zg/ml tosyl arginine methyl ester, 0.5 mM phenylmethylsulfonyl fuoride), boiled, and passed repeatedly through a 25-gauge needle. Protein concentrations were determined after trichloroacetie acid precipitation by the Lowry method (Lowry, 1951) , and samples were resolved by electrophoresis on 0.8-ram thick 8% SDSpolyacrylamide gels (70/~g protein/ram 2) and transferred electrophoretically to 0.22 t~m nitrocellulose (Schleicher and Schuell, Keene, NH). Approximately 2-ram wide strips were cut, and nonspecific protein-binding sites were blocked by incubating the strips in buffer W (2 % [wt/vol] hemoglobin in PBS) for at least 1 h at room temperature. The specimens were then incubated overnight with primary antibody (10 tzg/ml for anti-Cpep) in buffer W, washed three times with buffer X (buffer W containing 0.05 % [vol/vol] NP-40, and 0.1% [wt/vol] SDS), and two times in buffer W, incubated with t25I-protein A (2-10 tzCi/tzg) in buffer W for 1-2 h, washed two times with buffer X, and three times with PBS. Antibody binding was visualized by autogradiography. Control samples for Fig. 5 and 8 A were probed with anti-tubulin antiserum (not shown).
lmmunofluorescence Microscopy
On day 0, cells were plated (200 cells/ram 2) in medium C onto 12-mm square glass cover slips. On day 2, the cover slips were washed in ePBS (PBS with 0.5 mM MgCI2 and 0.9 mM CaC12) at 37"C, fixed for 30 rain at room temperature with 3.7% (vol/vol) formaldehyde in cPBS which was prewarmed to 37°C, and quenched for 10 rain at room temperature in 50 mM NI-hCI. Cells were then permeabilized for 10 min at room temperature in PBS containing 0.1% Triton X-100 and 0.02% SDS. The cover slips were then processed as follows: rinsed once quickly in PBS, preblocked for 30 rain at 37°C facedown on a 25-/~1 droplet of blocking solution (PBS, 5% FBS, 0.1% Triton X-100, 0.02% SDS) on parafilm, rinsed once with PBS, incubated for 90-120 min at 37°C with 25/~1 primary antibody diluted in blocking solution (affinity purified anti-Cpep, 3 t~g/ml; anti-B-COP monoclonal antibody M3A5, 1:2 dilution; and anti-mannosidase II, 1:1000 dilution), rinsed four times in PBS, incubated with fluorescently labeled seeondary antibody in blocking solution (FGAR, 1/1,000 or 1/2,000 dilution; FGAM, 1/500 dilution; or TRHAM, 1.5 ~g/ml) for 45-60 rain, rinsed four times in PBS and one time in H20, and mounted on Vinol gel (Air Products and Chemicals, Allentown, PA) with 1,4-diazabicyclo[2.2.2]octane (15 mg/ml) (Sigma). Double-staining experiments (e.g., see Fig. 7 ) were performed by simultaneous addition of two primary antibodies and then addition of the corresponding secondary antibodies. Control experiments (not shown) established that results from doubly stained samples were indistinguishable from those of singly stained samples. Cells were examined on a Zeiss axioplan microscope using 40x and 100× oil immersion objectives and fluoreseein or rhodamine filter packages, and photographed with Kodak T-max 400 film.
Other Methods
Lectin sensitivity assays were performed as previously described (Kingsley et al., 1986a) . The LD10 values presented represent estimates of the lectin concentrations which results in the killing of '~90% of the cells.
LDL receptor activity was determined using an 125I-LDL (10 #g protein/ml, 490 cprn/ng protein) degradation assay as described previously Krieger, 1983) . The high affinity degradation values shown represent the differences between measurements made in the absence (duplicate determinations) and presence (single determinations) of excess unlabeled LDL (400 t~g protein/ml) and are presented as rig of nSI-LDL degraded in 5 h per mg of cell protein. Protein concentrations were determined by the method of Lowry et al. (1951) .
Metabolic labeling of cells, immunoprecipitation of LDL receptors with an anti-COOH terminus anti-peptide antibody, electrophoresis, and autoradiography were performed as previously described (Kozarsky et al., 1986) .
Unless otherwise indicated, recombinant DNA and immunological techniques were performed as described in Sambrook et al. (1989) and liar-low and Lane (1988), respectively. Southern blot analyses were performed using Zetabind nylon filters (Curio Inc., Meriden, CT) and poly(A) + RNA Northern blot analyses using GeneScreen filters (DuPont NEN, Boston, MA).
Results
Cloning of the Human LDLC cDNA
To clone the LDLC gene, we adapted the strategy pioneered by Shih and Weinberg (1982) for the cloning of the ras oncogene (see Materials and Methods for details). In brief, human genomic DNA was transfected into ldlC cells, and LDL receptor-positive revertants which exhibited normal glycoconjugate synthesis were isolated using a nutritional selection method (MeLoCo, described in Krieger, 1986) . LDL receptor activity was determined using an LDL degradation assay, which measures the receptor-dependent internalization and lysosomal degradation of t2SI-LDL Krieger, 1983) . The global glycosylation defects in ldlC cells and their correction by transfection were detected using a lectin sensitivity assay (Stanley, 1985; Kingsley et al., 1986a) . Due to the altered structures of cell surface glycoconjugates in ldlC cells (Kingsley et al., 1986a) , these mutants, relative to wild-type CHO, are hypersensitive to the lectins concanavalin A (Con A) and ricin, and resistant to phytohemagglutinin (PHA) and wheat germ agglutinin (WGA). The transfectants from this first round of transfection/selection are designated primary (1 °) LETC cells (LDL Endocytosis Transfectants of ldlC). Genomic DNA from one 1 ° LETC line was transfected into ldlC cells to generate LDL receptor-positive secondary (2 °) LETC cells and an additional round of transfection and selection was used to isolate tertiary (3 °) LETC cells (not shown).
The presence of human DNA in the LETC cells was assessed by Southern blotting, using either total human genomic DNA or a cloned fragment of human repetitive DNA (Alu) as the probe (not shown). In all secondary and tertiary transfectants examined, there was a correlation of the presence of a 3.5-kbp EcoRI human DNA-containing fragment with the restoration both of LDL receptor activity p25I-LDL assay or growth in selective medium, see Materials and Methods) and of normal glycosylation (lectin sensitivity assay). This suggested that transfer of the human LDLC gene was probably responsible for the correction of the mutant phenotype in the transfected cells, and that the human LDLC gene was physically linked to the 3.5-kbp EcoRI fragment. Therefore, we used the Alu probe to clone this 3.5-kbp DNA fragment from a size-selected library of EcoRIdigested genomic DNA prepared from a 2 ° LETC colony.
A 600-bp Alu repeat-free SacI-HinclI restriction fragment from this 3.5-kbp clone was then used as a probe for Northern blot analysis (not shown). Under high stringency hybridization conditions, the probe recognized a single 3.1-3.5-kb mRNA from both 3 ° LETC-B6 cells and human HeLa cells, but not from untransfected ldIC or wild-type CHO cells.
Thus, this mRNA was likely to be the transcription product of the human gene that corrected the ldlC defects. We therefore used the SacI-HinclI fragment as a probe to isolate 16 overlapping human eDNA clones from two HeLa cell cDNA libraries (see Materials and Methods). The cloned DNA is designated LDLC eDNA. One of the clones, which comprises the entire predicted coding sequence (see below), was inserted into the vector pRc/CMV to generate the expression vector pLDLC-1.
Human LDLC cDNA Corrects the Abnormal Phenotypes of idiC Cells
Three distinguishing characteristics of ldlC cells are (a) dramatically reduced LDL receptor activity, (b) abnormal posttranslational processing (glycosylation) of LDL receptors and their consequent instability, and (c) global defects in cell surface glycoconjugates (Kingsley et al., 1986a) . To determine if pLDLC-1 could correct these mutant phenotypes, we isolated ldlC cells stably transfected with pLDLC-1. One transfectant, designated ldlC [LDLC] , was used in the experiments described below; all results were confirmed using independently generated transfectants (not shown). Control transfectants, designated ldlC[control] cells, were generated by transfection with the vector pRc/CMV lacking the eDNA insert. Table I shows the LDL receptor activities, determined using an t25I-LDL degradation assay, of wild-type CHO, ldlC, ldlC [LDLC] , and ldlC [controI] cells. In the experiment shown, transfection of ldlC cells with pLDLC-1, but not with the empty vector, restored LDL receptor activity to 61% of wild-type levels. Analysis of other independent transfectants showed that pLDLC-1 restored receptor activity to levels as high as 160% of wild type (not shown). Therefore, human LDLC eDNA restored normal LDL receptor activity to ldlC cells. Fig. 1 shows the posttranslational processing of LDL receptors, using a pulse/chase immunoprecipitation assay (Kozarsky et al., 1986) . In wild-type CHO ceils the LDL receptor was synthesized as a ,,o125 kD precursor (p) which was rapidly converted to a ~155 kD mature form (m) (Fig.   1, top) . Previous experiments have established that the precursor is an endoglycosidase H sensitive ER protein, that is processed to an endoglycosidase H resistant, sialylated, mature protein during transport through the Golgi apparatus to the cell surface (Tolleshaug et al., 1982; Cummings et al., 1983; Kozarsky et al., 1986) . The shift in electrophoretic mobility between the precursor and mature forms is due to maturation of the numerous O-linked and several N-linked oligosaccharides on the receptor. The mature form of the receptor is stable, with a half-life of '~16-20 h. The band of lower apparent mass (d) represents a previously described degraded form of the receptor (Fig. 1, top , and see Lehrman et al., 1985; Kozarsky et al., 1986) . In contrast, the LDL receptor in ldlC cells was converted from an apparently normal precursor to a heterogeneous mixture of abnormally glycosylated intermediates, with significantly lower stability than that of the mature receptor in wild-type cells. (Fig. 1, middle, and see Kingsley et al., 1986a) . These abnormally glycosylated LDL receptors are transported to the cell surface, where they can bind LDL with normal affinity and mediate endocytosis; their dramatically reduced stability is the primary cause of the reduction in receptor activity in ldlC cells (Kingsley et al., 1986; . In IdlC[LDLC] cells (Fig. 1, bottom) , LDL receptor posttranslational processing and stability were restored to those seen in wild-type cells, while processing and stability in ldlC-
[control] cells remained essentially identical to those in untransfected ldlC cells (not shown). Therefore, the human LDLC cDNA corrected the abnormal posttranslational glycosylation and instability of LDL receptors in ldlC cells.
To determine if pLDLC-1 corrected the global abnormalities in the synthesis of N-linked, O-linked, and lipid-linked oligosaccharides in ldlC ceils, we measured the lectin sensitivities of these transfected and untransfected cells. Table I 
Expression of LDLC in l~ld-type, Mutant, and Transfected Cells
Plasmid pLDLC-1 could encode the human homologue of the defective gene in ldlC cells, or an extragenic suppressor of this gene (e.g., see Rine, 1991; . To address this issue, we examined by Northern blot analysis the expression of the endogenous LDLC gene in ldlC cells (Fig. 2, top) . The human LDLC probe recognized a single mRNA band of ~ 3.4 kb in human HeLa cells, in a 3 ° LETC colony, and in wild-type CHO Cells. The somewhat reduced intensity of the band in CHO cells relative to HeLa and 3 ° LETC cells was presumably due to imperfect sequence complementarity between the human and hamster homologues.
Strikingly, this hamster LDLC mRNA was essentially undetectable in ldlC ceils, although a longer exposure revealed a very faint signal (not shown). Examination of the same filter with a control tubulin probe indicated that comparable levels of mRNA were loaded for each of the samples (Fig.   2, bottom) . The dramatically reduced levels of LDLC mRNA in ldlC cells relative to wild-type CHO cells reflects either decreased synthesis or increased degradation of the LDLC mRNA. Therefore, a mutation in the LDLC gene itself, or, perhaps less likely, in a gene which regulates LDLC mRNA expression, is responsible for the mutant phenotypes of ldlC cells. transfectants. On day 0, the indicated cells were plated in 6-well dishes (150,000 cells/ well in medium E). On day 2, the cells were pulse-labeled with [35S]methionine (180 #Ci/ml) in methionine-free medium E for 30 min, washed once with Ham's FI2 medium, and then chased for the indicated times in medium E supplemented with 1 mM unlabeled methionine. The cells were then lysed and the lysates subjected to immunoprecipitation with an anti-LDL receptor antibody as described in Materials and Methods. The immunoprecipitates were reduced with B-mercaptoethanol, and analyzed by 6% SDS-polyacrylamide gel electrophoresis and autoradiography as previously described (Kozarsky et al., 1986) open reading frame. The hybridization and washing conditions were chosen to permit hybridization of the human probe to hamster mRNA. Prehybridization and hybridization were carded out at 60 ° in 500 mM phosphate buffer (pH 7.0), 7 % SDS, 1 mM EDTA, 10 mg/ml BSA, and 0.1 mg/ml sheared salmon sperm DNA. Washes were as follows: 2 x 15 min at room temperature in 300 mM phosphate buffer (pH 7.0); 2 × 15 min at 60 ° in 300 mM phosphate buffer, 5% SDS, 5 mg/ml BSA, 1 mM EDq'A; and 2 × 15 min at 60 ° in 300 mM phosphate buffer, 1% SDS, and 1 mM EDTA. The arrows indicate the positions of the two major ribosomal RNA bands. (Bottom) The same filter was stripped and reanalyzed using a portion of/~-tubulin cDNA as a probe. quence surrounding the putative initiator methionine (amino acid no. 1) is consistent with the consensus sequence described by Kozak (1989) . This ATG is preceded by a 95-bp 5' untranslated region, which includes an in-frame stop codon seven triplets upstream of the start methionine. The 2214-bp open reading frame is followed by a 595-bp 3' untranslated region. A 154-bp sequence within the SacI-HinclI genomic fragment used to clone the cDNA was identical to the corresponding sequence in the cDNA (bases 1227-1380). This region of the genomic DNA was flanked at both ends by unrelated sequence, suggesting that this overlap defines a single exon within the LDLC gene (see arrowheads in Fig. 3) .
Human LDLC cDNA Encodes a Novel Cytosolic Protein
Podos et al. IdlCp and Golgi Function
The predicted protein product (ldlCp) of the human LDLC gene has a calculated mass of 83,207 D. Surveys of various DNA and protein sequence databases have revealed no similarities to any known genes or proteins. Furthermore, we have detected no signal sequences for translocation into the ER, and no candidate transmembrane domains. This suggests that the ldlCp is a novel, soluble protein which does not enter the secretory pathway and is probably a cytoplasmic protein. Thus, it appears that LDLC encodes a protein that influences lumenal Golgi reactions from the cytoplasm. In addition, we have not detected any other common sequence motifs or predicted secondary or tertiary structural elements, such as isoprenylation sequences, amino terminal N-myristylation sites, nucleotide binding sites, heptad repeats, etc.
We have found no notable sequence similarities between LDLC and known genes reported in databases such as GenBank and EMBL. However, the LDLC cDNA sequence was significantly similar to three expressed sequence tags (ESTs), cDNA fragments which were cloned and sequenced at random. Two of the ESTs were derived from human cDNA libraries (EST01264 from hippocampus, GenBank no. M79116, Adams et al., 1992; and EST clone HEB069 from heart atrium, GenBank no. Z25929, Genexpress, unpublished observations). These two ESTs are nearly identical to the LDLC cDNA from bases 1805 through 2072 (99% identity) and from 1674 through 1875 (96% identity), respectively. The few mismatches are probably due either to polymorphisms or to sequence errors arising from the preliminary nature of EST sequences (Adams et al., 1991 
Cloning of an LDLC homologue from C. elegans
The C. elegans EST clone is 382 bases long, and includes a 203-bp region which is 60% identical to bases 40-242 of the human LDLC cDNA. Furthermore, the predicted amino acid sequence within this region is 49% identical and 70% similar to the human ldlCp sequence. Therefore, the gene represented by this EST was a good candidate for an invertebrate homologue of the LDLC gene. To characterize the putative homologue, we used this EST to isolate six C. elegans cDNA clones. Each was '~2.0 kbp long, and they all had similar restriction maps. One clone was sequenced fully on both strands (see Fig. 4 A) . Its 2222 base sequence includes an open reading frame of 681 codons from the first methionine (Fig. 4 A) . The sequence surrounding the putative initiator codon is consistent with the consensus sequence described by Kozak (1989) . The reading frame is preceded by a putative 31-bp 5' untranslated region which lacks in-frame stop codons; this 5' untranslated region includes a T~s which may be an artifact of cDNA synthesis. The open reading frame is followed by a 148-bp 3' untranslated region which includes a 20-bp polyadenylate tail. Throughout their lengths, the predicted protein sequences of the C. elegans (calculated mass of 78,565 D) and human ldlCp homologues are 26 % identical and 53 % similar when aligned as in Fig. 4 B. The first methionine in the human sequence best corresponds to the methionine at position 10 of the C. elegans sequence, raising the possibility that the first nine amino acids of the C. elegans sequence in Fig. 4 A may not be translated. These nine residues include a potential myristylation site. As with its human counterpart, the nematode ldlCp sequence lacks other notable structural features such as transmembrane domains or signal sequences. Overall, the conservation in the human and nematode ldlCp sequences suggests that the LDLC genes encode proteins which mediate important, highly conserved functions.
Preparation and Characterization of Anti-ldlCp Antibodies
Based on the abnormalities in medial and trans Golgiassociated glycoconjugate synthesis in ldlC cells, we inferred that cytosolic ldlCp might physically associate with the Golgi apparatus. To determine the subcellular distribution of ldlCp by inununofluorescence microscopy, rabbit polyclonal antibodies were prepared using synthetic peptides which represent the amino (Npep)-and carboxy (Cpep)-termini of human ldlCp, and are designated anti-Npep and anti-Cpep, respectively. Both immunoprecipitation and immunoblot analyses (not shown) established that anti-Npep and anti-Cpep antibodies bound to an '~76-kD protein which was present in HeLa cells (not shown). This binding was specifically blocked by an excess of soluble peptide, and this 76-kD protein, whose apparent mass is similar to the 83-kD predicted from the LDLC sequence, was not detected when either preimmune serum was used.
Anti-Cpep was affinity purified on a Cpep-agarose column, and its specificity was assessed by immunoblot analysis. Fig. 5 compares the immunoblotting patterns of preimmune IgG (p) and anti-Cpep (C), measured in the absence (-) or presence (+) of an excess of the Cpep peptide. Purified anti-Cpep, but not preimmune IgG, bound to an •76-kD protein in both human HeLa cell and murine 3T3 cell lysates (anti-Cpep, Fig. 5 , lanes 2 and 5; preimmune IgG, lanes 1 and 4). This binding was competed by excess Cpep, suggesting that it may correspond to ldlCp (Fig. 5,  lanes 3 and 6) . Anti-Cpep, but not preimmune IgG, also recognized two smaller species in the HeLa cell lysates (Fig. 5,  lanes I and 2) ; however, this binding was not inhibited by excess Cpep (lane 3). The identities of these smaller molecules and the significance of their recognition here are unknown. Anti-Cpep also specifically recognized the ~76-kD endogenous hamster IdlCp in CHO cell lysates (Fig. 5, lanes 7-9) . The ~76-kD protein was not detected in lysates from ldlC ceils (Fig. 5, lanes 10 and 1/) , but was seen in IdlC [LDLC] lysates (lanes 12 and 13). (Replicate lanes of CHO, ldlC, and ldlC [LDLC] lysates, stained with anti-tubulin antiserum, showed that these samples contained equivalent amounts of protein [not shown]). These results are consistent with the dramatically reduced levels of LDLC mRNA observed in ldlC cells (Fig. 2) . As was the case for HeLa cell lysates, anti-Cpep bound to smaller, unidentified species from CHO and ldlC cells. Taken together, these data establish that the •76-kD protein, which is the major specific antigen of antiCpep, is ldlCp and they suggest that at least a portion of the COOH terminus of ldlCp is conserved among several mammalian species.
lmmunolocalization of ldlC Protein
Immunofluorescence microscopy with affinity purified antiCpep was used to determine the distribution of ldlCp within wild-type CHO cells. Fig. 6 a (top left) shows that the major anti-Cpep signal in CHO cells emanated from clearly defined, punctate, and sometimes annular, structures surrounding the nucleus. This perinuclear staining was absent from ldlC cells but present in transfected IdlC [LDLC] cells (see below), and was largely competed by a 10-fold molar excess of soluble Cpep (not shown). Thus, the perinuclear staining represents the localization of ldlCp. A fine, granular, yet otherwise uniform, background was often present. This background was resistant to Cpep competition, and was indistinguishable from the staining pattern observed with preimmune IgG or in controls in which the primary antibody was omitted (not shown).
The perinuclear distribution of ldlCp was characteristic of the distribution of the Golgi apparatus in CHO cells (Kao and Draper, 1992; Guo et al., 1994) . For example, Fig. 6 (top row) also shows the staining of CHO cells with antibodies against two Golgi-associated proteins: fl-COP (b) and mannosidase II (c). fl-COP is a subunit of the Golgi coatomer complex, which associates reversibly with Golgi membranes and which is a major component of the protein coat on Golgiderived transport vesicles (Duden et al., 1991; grown to confluence and lysed, and the lysates subjected to immunoblot analysis using either preimmune IgG 00/zg/ml, p) or antiCpep (10 t~g/ml, C), the latter in the presence (+) or absence (-) of a 10-fold molar excess (2 #g/ml) of the Cpep peptide. Bound antibody was detected autoradiographically using ~25I-Protein A. The "ldlCp ~ (/arge arrow) indicates the position of the various mammalian ldlCp's, as described in Results. al., 1991; Waters et al., 1991; Ostermann et al., 1993) . Mannosidase II is an integral membrane protein required for normal processing of N-linked oligosaccharide chains in the lumen of the Golgi apparatus (Moremen and Touster, 1985) . The perinuclear immunofluorescence of ldlCp and t-COP colocalized (Fig. 6 , a and b show essentially the same field from a doubly-stained sample), and their distributions clearly resembled that of mannosidase II. Thus, ldlCp appears to be a Golgi-associated protein in wild-type CHO cells. Similar results were obtained using 3T3 cells (not shown).
Effects of Brefeldin A on the Localization of ldlCp
Because the sequence of ldlCp suggested that it is a cytosolic protein, it appeared likely that ldlCp would associate peripherally, rather than integrally, with Golgi membranes. We therefore compared the behavior of ldlCp with those of the peripheral Golgi protein/3-COP and the integral membrane protein rnannosidase II, when the structure of the Golgi apparatus was disrupted with the drug brefeldin A (BFA) (Takatsuki and Tamura, 1985; Fujiwara et al., 1988; Donaldson et al., 1990; Lippincott-Schwartz et al., 1989 , 1990 Orci et al., 1991) . BFA interferes with the assembly of the coatomer complexes onto Golgi membranes resulting in the division of Golgi-associated proteins into at least two kinetically and morphologically distinguishable groups. ~COP and other peripherally associated coat proteins rap- idly redistribute from the Golgi surface into the cytoplasm (Donaldson et al., 1990) . Subsequently, the Golgi membranes and their integrally associated proteins, such as mannosidase II, more slowly fragment into tubules and vesicles, which then mix with the endoplasmic reticulum. The effects of BFA on the distributions of B-COP and mannosidase II are reversed after the drug is removed from the cells (Donaldson et al., 1990 ). (Fig. 6 , second row), perinuclear ldlCp was reduced but still evident, and the cytoplasmic staining increased (d). After 5 min (third row), only small remnants of perinuclear staining were observed (g). In this regard, the effects of BFA on the distribution of ldlCp resembled those on ~-COP, which was reduced in intensity after 2 rain and dispersed after 5 min (e and h). In contrast, mannosidase II staining was largely unchanged after 2 min (f). After 5 min it had transformed into a more contiguous pattern which included some fiber-like projections (i), as previously de-scribed (Lippincott-Schwartz et al., 1990) . Thus, after 5 min of BFA treatment, the staining of ldlCp and of/3-COP were distinct from that of marmosidase II. The staining with all three antibodies was almost fully dispersed after 20 rain of BFA treatment, and was restored to an essentially normal distribution after the BFA was removed and the cells were permitted to recover for 30 min (not shown). Taken together with the predicted sequence of ldlCp, these data strongly suggest that ldlCp is peripherally associated with the Golgi apparatus and its association appears similar to that of &coP.
To determine if ldlCp was required to maintain the normal structure of the Golgi apparatus, we compared the distributions of/~-COP and mannosidase II in CHO, ldlC, and ldlC[LDLC] cells. Fig. 7 shows that the distributions of /~-COP (center column) and mannosidase 1I (right column)
were essentially identical in all three types of cells, regardless of the presence or absence of ldlCp (left column). Thus, expression of ldlCp was not required for the formation of the Golgi. It should be noted that the intensities of the perinuclear staining of the Golgi markers varied among these cell types. In general, there was a tendency for somewhat reduced perinuclear/~-COP and mannosidase II staining intensity in ldlC cells. Expression of the transfected human ldlCp in IdlC[LDLC] cells elevated the intensity of these two markers to wild-type, and often even greater than wild-type levels. The significance of these differences in staining intensities remains unclear, but may reflect a subtle role of ldlCp in regulating the structure or quantity of Golgi membranes.
Aberrant Distribution of ldlCp in ldlB Cells Indicates Golgi Localization Is Required for IdlCp Function
The BFA-dependent reversible localization of ldlCp to the Golgi suggested that, as with 13-COP, Golgi localization may be required for the effects of ldlCp on Golgi function. This suggestion was supported by studies of ldlCp's distribution in another class of CHO cell mutant, ldlB. ldlC and ldlB cells are genetically distinct; they define discrete recessive complementation groups (Kingsley and Krieger, 1984) , and transfection of the cloned LDLC cDNA into ldlB cells did not correct the pleiotropic defects of ldlB cells (not shown). Nevertheless, the mutant phenotypes of ldlB and ldlC cells are virtually indistinguishable: reduced LDL receptor activity, abnormal posttranslational processing and stability of LDL receptors, and global defects in cell surface glycoconjugates (Kingsley et al., 1986a) . This raised the possibility that the LDLB gene could exert its effects on Golgi function by regulating the expression or function of the LDLC gene or of ldlCp. We therefore examined the expression of the endogenous LDLC gene and the localization of ldlCp in a clone of ldlB cells, designated ldlB-ll, and in a secondary human genomic DNA transfectant of ldlB-11 cells, designated 2 ° LETB-144, in which the mutant phenotypes had reverted to wild type (Kingsley et al., 1986b) .
Northern blot analysis (not shown) and immunoblot analysis (Fig. 8 A) established that there were essentially wildtype levels of both LDLC mRNA and ldlCp, in both ldlB-11 and 2 ° LETB-144 cells. Thus, LDLB gene function was not required for the synthesis or maintenance of normal steadystate levels of ldlCp. and mannosidase II (right column) in wild-type CHO (first row), ldlB-11 (second row), and 2 ° LETB-144 cells (third row). In contrast to its typical Golgi localization in wild-type CHO cells (a), ldlCp apparently did not localize to the Golgi apparatus in ldlB-11 ceils (d). Instead, a uniform punctate background in ldlCp staining was seen, suggesting that ldlCp was distributed throughout the cytoplasm of ldlB-11 cells. These results were confirmed by examining an independently derived clone of ldlB cells (WGAr-2, Kingsley et al., 1986a) (not shown). In addition, the normal Golgi distribution of ldlCp was restored in 2 ° LETB-144 ceils (g). In both ldlB-11 and 2 ° LETB-144 cells, there were essentially wildtype distributions of/~-COP (center column, b, e, and h) and mannosidase II (right column, c, f, and i), indicating that the Golgi in these cells was essentially normal. As was the case for ldlC cells, there was a tendency for the intensity of immunofluorescence to be lower in the mutant than in wild-type or phenotypically reverted transfected cells; the significance of this observation is unclear. Taken together, these results establish that the LDLB gene is necessary for ldlCp localization to the Golgi and raise the possibility that the distinctive mutant phenotypes of ldlB cells are primarily due to abnormal localization of ldlCp. (Kingsley et al., 1986a) . Essentially identical defects are found in a genetically distinct class of CHO mutants, ldlB cells. All of these abnormalities arise from pleiotropic defects in multiple medial and trans Golgi-associated processes (Kingsley et al., 1986a) . The complex nature of these defects suggests that the LDLB and LDLC genes may be critically important for generating or maintaining the compartmental organization or the intralumenal environment of the Golgi apparatus (Kingsley et al., 1986a ).
Discussion
In the current study, we cloned a human LDLC cDNA which corrects the mutant phenotypes of ldlC, but not ldlB, cells. Unlike wild-type CHO or ldlB cells, ldlC cells had virtually no detectable endogenous LDLC mRNA, suggesting that LDLC is the normal human homologue of the defective gene in ldlC cells. Alternatively, the cloned LDLC gene may have acted as an extragenic suppressor of the defective gene in the ldlC cells. In either case, it appears that the gene which is defective in ldlC cells either directly or indirectly controls the expression of the LDLC mRNA and its protein product (ldlCp), and ldlCp apparently plays an important role in the normal functioning of the Golgi.
The predicted sequence of ldlCp is novel, lacking significant similarity to other known proteins. A portion of the ldlCp sequence was, however, highly similar to that of an EST cDNA fragment from the nematode C. elegans. We cloned and sequenced the C. elegans cDNA, and found a high degree of sequence similarity throughout the entire lengths of the mammalian and nematode sequences (26% identity, 53 % similarity). This similarity suggests that ldlCp plays an ancient role in eukaryotic cell biology. The highly conserved portions of these sequences should facilitate the construction of probes which will permit the identification of ldlCp homologues from other species, possibly including the yeast Saccharomyces cerevisiae. Genetic studies in C. elegans and S. cerevisiae should help further define the functions of ldlCp.
The predicted sequence of ldlCp has no major common structural motifs such as GTP binding sites, transmembrane domains, or an ER translocation signal sequence. This suggests that ldlCp is a cytoplasmic protein. Nevertheless, immunofluorescence studies indicated that ldlCp may be associated with the cytoplasmic face of the Golgi, as it colocalized with Golgi markers and was rapidly redistributed from the Golgi by the drug BFA. Thus, the association of ldlCp with the Golgi appears to be analogous to that of several other peripheral Golgi proteins, including p200 (Narula et al., 1992) , the coatomer (Donaldson et al., 1990; Orci et al., 1991) , the small GTPase ADP-ribosylation factor (ARF) , clathrin, and type I clathrinassociated proteins (Robinson and Kreis, 1992; Stamnes and Rothman, 1993; Traub et al., 1993) , most of which have been implicated in intracellular membrane transport. Because ARF and coatomer proteins cycle on and off of Golgi membranes in a guanine nucleotide-dependent fashion (for example see Donaldson et al., 1992; Helms and Rothman, 1992; Klausner et al., 1992) , it seems likely that ldlCp may undergo similar cycling between the cytoplasm and the Golgi membranes. The relative amounts of Golgi-associated and cytoplasmic ldlCp and the affinity of ldlCp for Golgi membranes have not yet been determined. The reversible nature of ldlCp association with the Golgi suggests that the association may be regulated. Regulated association of Golgi proteins has been implicated in the mitotic disassembly of the Golgi, as well as in normal trafficking during interphase (Rothman and Warren, 1994) . Analysis of ldlB mutants suggested that the association of ldlCp with the Golgi apparatus is required for its normal function. Essentially wild-type levels of ldlCp were present in ldlB cells; however, immunofluorescence microscopy indicated that the ldlCp was not localized to the Golgi complex in ldlB ceils. A simple model, which accounts for the virtually identical phenotypes of ldlB and ldlC cells (Kingsley et al., 1986a) , is that the product of the LDLB gene is required for the Golgi association of ldlCp and that this association is required for ldlCp function. When this association is prevented, due either to the absence of the ldlCp or to the loss of functional ldlBp, normal Golgi processing reactions are disrupted (See Fig. 9 ). ldlBp might serve as a Golgi receptor for ldlCp, a component of a heterooligomer with ldlCp, or a processing enzyme that renders ldlCp competent to bind to Golgi membranes. Further experiments will be required to determine how ldlBp influences the localization and activity of ldlCp, and what other roles the LDLB gene may play in normal Golgi functions.
The mechanism by which ldiCp influences lumenal Golgi processing reactions has not yet been established. At the resolution of the immunofluorescence microscopy described here, we observed no major defects in the ultrastructure of the Golgi in ldlC cells. Nevertheless, ldlCp might play a role in determining the compositions of the Golgi's membranes or lumenal spaces, including the amounts or types of proteins, lipids, carbohydrates, or ions present. Alterations in the localization or amounts of these components could interfere with multiple Golgi processing reactions. For example, the distributions of enzymes within the Golgi may depend on the distributions of lipids (Bretscher and Munro, 1993) . It is also possible that the membrane association of ldlCp, which is BFA sensitive, is required for normal membrane trafficking through the Golgi. A defect in transport through one or more of the Golgi stacks might result in pleiotropic processing defects without grossly disrupting either the Golgi's ultrastructure or protein transport to the cell surface. Additional biochemical and genetic studies will be required to determine the functions of ldlCp, and how these functions contribute to the normal activity of the Golgi apparatus.
